The big pharma and AI drug developer expand on a partnership that launched with a 2023 software licensing accord.

Disappointed investors punished Wave Life Sciences (NASDAQ: WVE), causing its shares to lose roughly half their value on Thursday after the RNA-based drug developer reported mixed early-stage interim ...

The data showed that roughly 65% of the cells in the oxygenated devices remained viable compared to roughly 20% in control devices.

Researchers suggest modulating intestinal microbiota or antigen-presenting activity of IECs represents new approaches to treating autoimmune neurological disease.

Many organizations still lack structured media optimization and alignment between development and manufacturing, according to Lonza.

The data shows that inhibiting TIE2 with rebastinib could prevent new abnormalities from forming in the brain with fewer side effects.

GEN Live panelists will explore how stem cells are transforming disease modeling, drug discovery, and personalized medicine with perspectives on clinical trial progress and hurdles such as ...

Beyond resistance‑associated genes, the researchers uncovered deep geographic population structure and high overall genetic diversity.

Study findings indicate that environmentally relevant doses of OLA bioplastics may be “more toxic” to the placenta than ...

The connection between cancer response and autoimmune disease in the brain lies with the antibodies deployed to fight cancer.